Network Pharmacology Analysis of Orally Bioavailable SARS-CoV-2 Protease Inhibitor Shows Synergistic Targets to Improve Clinical Efficacy

MLA

Arun HS Kumar. “Network Pharmacology Analysis of Orally Bioavailable SARS-CoV-2 Protease Inhibitor Shows Synergistic Targets to Improve Clinical Efficacy.” Biology, Engineering, Medicine and Science Reports, vol. 7, Oct. 2021, pp. 21–24. EBSCOhost, https://doi.org/10.5530/bems.7.2.8.

APA

Arun HS Kumar. (2021). Network Pharmacology Analysis of Orally Bioavailable SARS-CoV-2 Protease Inhibitor Shows Synergistic Targets to Improve Clinical Efficacy. Biology, Engineering, Medicine and Science Reports, 7, 21–24. https://doi.org/10.5530/bems.7.2.8

Chicago

Arun HS Kumar. 2021. “Network Pharmacology Analysis of Orally Bioavailable SARS-CoV-2 Protease Inhibitor Shows Synergistic Targets to Improve Clinical Efficacy.” Biology, Engineering, Medicine and Science Reports 7 (October): 21–24. doi:10.5530/bems.7.2.8.